Akebia Therapeutics, Inc.
AKBADrugs in Pipeline
8
Phase 3 Programs
4
Upcoming Catalysts
3
Next Catalyst
Aug 6, 2026
8dMarket Overview
Stock performance and key metrics
3 upcoming, 0 past
AKBA Earnings Report
EPS Est: $-0.03 | FQ end 2026-06
2 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How AKBA's past catalysts played out
Erythropoiesis-Stimulating Agent (ESA)
Anemia of Chronic Kidney Disease
Vadadustat
Anemia
Mircera®
Anemia Associated With Chronic Kidney Disease (CKD)
Darbepoetin alfa
Anemia
IW-1973
Heart Failure With Preserved Ejection Fraction
Epoetin Alfa
Anemia
AKB-6548
Anemia
Praliciguat
Focal Segmental Glomerulosclerosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Erythropoiesis-Stimulating Agent (ESA) | Phase 3 | Anemia of Chronic Kidney Disease | - | - |
Vadadustat | Phase 3 | Anemia | - | - |
Mircera® | Phase 3 | Anemia Associated With Chronic Kidney Disease (CKD) | - | - |
Darbepoetin alfa | Phase 3 | Anemia | - | - |
IW-1973 | Phase 2 | Heart Failure With Preserved Ejection Fraction | - | - |
Epoetin Alfa | Phase 2 | Anemia | - | - |
AKB-6548 | Phase 2 | Anemia | - | - |
Praliciguat | Phase 2 | Focal Segmental Glomerulosclerosis | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Akebia Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in Akebia Therapeutics, Inc.'s (AKBA) pipeline across Phase 3, Phase 2. Its lead program is Erythropoiesis-Stimulating Agent (ESA) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Akebia Therapeutics, Inc.'s next FDA catalyst?→
Akebia Therapeutics, Inc.'s (AKBA) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track AKBA biotech catalysts?→
Add AKBA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Akebia Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.